Amyotrophic lateral sclerosis, lead, and genetic susceptibility: Polymorphisms in the δ-aminolevulinic acid dehydratase and vitamin D receptor genes

Environmental Health Perspectives

Volumn 111, Issue 10, 2003, Pages 1335-1339

  Kamel, Freya ^a   Umbach, David M ^a   Lehman, Teresa A ^b   Park, Lawrence P ^f   Munsat, Theodore L ^c   Shefner, Jeremy M ^d   Sandler, Dale P ^a   Hu, Howard ^e   Taylor, Jack A ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b Bioserve Biotechnologies   (United States)

^c TUFTS MEDICAL CENTER   (United States)

^d SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f NONE

Author keywords

Amyotrophic lateral sclerosis; Genetic susceptibility lead; Vitamin D receptor; aminolevulinic acid dehydratase

Indexed keywords

LEAD; PORPHOBILINOGEN SYNTHASE; VITAMIN D RECEPTOR;

ALLELE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BLOOD LEVEL; BONE LEVEL; CASE CONTROL STUDY; CONTROLLED STUDY; DATA ANALYSIS; DNA POLYMORPHISM; ENVIRONMENTAL EXPOSURE; ENZYME POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; OCCUPATIONAL EXPOSURE; PATELLA; PRIORITY JOURNAL; RECEPTOR GENE; RISK FACTOR; STATISTICAL ANALYSIS; TIBIA; TIME; UNITED STATES;

EID: 0042975395     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.6109     Document Type: Article

References (37)

1. Al-Chalabi A, Leigh PN. 2000. Recent advances in amyotrophic lateral sclerosis. Curr Opin Neurol 13(4):397-405.
2. Alexander BH, Checkowy H, Costa-Mallen P, Faustman EM, Woods JS, Kelsey KT, et al. 1998. Interaction of blood lead and delta-aminolevulinic acid dehydratase genotype on markers of heme synthesis and sperm production in lead smelter workers. Environ Health Perspect 106:213-216.
3. Aro ACA, Todd AC, Amarasiriwardena C, Hu H. 1994. Improvements in the calibration of CD-109 K x-ray fluorescence systems for measuring bone lead in vivo. Phys Med Biol 39(12):2263-2271.
4. Bellinger D, Hu H, Titlebaum L, Needleman HL. 1994. Attentional correlates of dentin and bone lead levels in adolescents. Arch Environ Health 49(2):98-105.
5. Bergdahl IA, Gerhardsson L, Schutz A, Desnick RJ, Wetmur JG, Skerfving S. 1997a. Delta-aminolevulinic acid dehydratase polymorphism: influence on lead levels and kidney function in humans. Arch Environ Health 52(2):91-96.
6. Bergdahl IA, Grubb A, Schutz A, Desnick R., Wetmur JG, Sassa S, et al. 1997b. Lead binding to delta-aminolevulinic acid dehydratase (ALAD) in human erythrocytes. Pharmacol Toxicol 81(4):153-158.
7. Brooks BR. 1994. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 124(suppl):96-107.
8. Burger DE, Milder FL, Morsillo PR, Adams BB, Hu H. 1990. Automated bone lead analysis by K-x-ray fluorescence for the clinical environment. Basic Life Sci 55:287-292.
9. Cooper GS, Umbach DM. 1996. Are vitamin D receptor polymorphisms associated with bone mineral density? A metaanalysis. J Bone Min Res 11(12):1841-1849.
10. Fleming DEB, Chettle DR, Wetmur JG, Desnick RJ, Robin JP, Bouleay D, et al. 1998. Effect of the delta-aminolevulinate dehydratase polymorphism of the accumulation of lead in bone and blood in lead smelter workers. Environ Res A77:49-61.
11. Fullmer CS. 1992. Intestinal interactions of lead and calcium. Neurotoxicology 13(4):799-807.
12. Hsieh LL, Liou SH, Chen YH, Tsai LC, Yang T, Wu TN. 2000. Association between aminolevulinate dehydrogenase genotype and blood lead levels in Taiwan. J Occup Environ Med 42(2):151-155.
13. Hu H, Rabinowitz M, Smith D. 1998. Bone lead as a biological marker in epidemiologic studies of chronic toxicity: conceptual paradigms. Environ Health Perspect 106:1-8.
14. Hu H, Wu MT, Cheng Y, Sparrow D, Weiss S, Kelsey K. 2001. The delta-aminolevulinic acid dehydratase (ALAD) polymorphism and bone and blood lead levels in community-exposed men: the Normative Aging Study. Environ Health Perspect 109:827-832.
15. Kamel F, Umbach DM, Munsat TL, Shefner JM, Hu H, Sandler DP. 2002. Lead exposure and amyotrophic lateral sclerosis. Epidemiology 13(3):311-319.
16. Kelada SN, Shelton E, Kaufmann RB, Khoury MJ. 2001. Delta-aminolevulinic acid dehydratase genotype and lead toxicity: a HuGE review. Am J Epidemiol 154(1):1-13.
17. Lee BK, Lee GS, Stewart WF, Ahn KD, Simon D, Kelsey KT, et al. 2001. Associations of blood pressure and hypertension with lead dose measures and polymorphisms in the vitamin D receptor and delta-aminolevulinic acid dehydratase genes. Environ Health Perspect 109:383-389.
18. Lee SS, Lee BK, Lee GS, Stewart WF, Simon D, Kelsey K, et al. 2001. Associations of lead biomarkers and delta-aminolevulinic acid dehydratase and vitamin D receptor genotypes with hematopoietic outcomes in Korean lead workers. Scand J Work Environ Health 27(6):402-411.
19. Lehman TA, Haffty BG, Carbone CJ, Bishop LR, Gumbs AA, Krishnan S, et al. 2000. Elevated frequency and functional activity of a specific germ-line p53 intron mutation in familial breast cancer. Cancer Res 60:1062-1069.
20. Longnecker MP, Kamel F, Umbach DM, Munsat TL, Shefner JM, Lansdell LW, et al. 2000. Dietary intake of calcium, magnesium and antioxidants in relation to risk of amyotrophic lateral sclerosis. Neuroepidemiology 19(4):210-216.
21. Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, et al. 1994. Prediction of bone density from vitamin D receptor alleles. Nature 367(6460):284-287.
22. Nelson LM. 1995-1996. Epidemiology of ALS. Clin Neurosci 3(6):327-331.
23. NIEHS. 2003. GeneSNPs. Research Triangle Park, NC:National Institute of Environmental Health Sciences. Available: http://www.genome.utah.edu/genesnps/ [accessed 9 June 2003].
24. Schwartz BS, Lee BK, Lee GS, Stewart WF, Simon D, Kelsey K, et al. 2000a. Associations of blood lead, dimercaptosuccinic acid-chelatable lead, and tibia lead with polymorphisms in the vitamin D receptor and [delta]-aminolevulinic acid dehydratase genes. Environ Health Perspect 108:949-954.
25. Schwartz BS, Lee BK, Stewart W, Ahn KD, Springer K, Kelsey K. 1995. Associations of delta-aminolevulinic acid dehydratase genotype with plant, exposure duration, and blood lead and zinc protoporphyrin levels in Korean lead workers. Am J Epidemiol 142(7):738-745.
26. Schwartz BS, Lee BK, Stewart W, Sithisarankul P, Strickland PT, Ahn KD, et al. 1997. delta-Aminolevulinic acid dehydratase genotype modifies four hour urinary lead excretion after oral administration of dimercaptosuccinic acid. Occup Environ Med 54(4):241-246.
27. Schwartz BS, Stewart WF, Kelsey KT, Simon D, Park S, Links JM, et al. 2000b. Associations of tibial lead levels with Bsml polymorphisms in the vitamin D receptor in former organolead manufacturing workers. Environ Health Perspect 108:199-203.
28. Sithisarankul P, Schwartz BS, Lee BK, Kelsey KT, Strickland PT. 1997. Aminolevulinic acid dehydratase genotype mediates plasma levels of the neurotoxin, 5-aminolevulinic acid, in lead-exposed workers. Am J Ind Med 32(1):15-20.
29. Smith CM, Hu H, Wang X, Kelsey KT. 1995a. ALA-D genotype is not associated with HT or HB levels among workers exposed to low levels of lead. Med Lav 86(3):229-235.
30. Smith CM, Wang X, Hu H, Kelsey KT. 1995b. A polymorphism in the delta-aminolevulinic acid dehydratase gene may modify the pharmacokinetics and toxicity of lead. Environ Health Perspect 103:248-253.
31. Waksberg J. 1978. Sampling methods for random digit dialing. J Am Statis Assoc 73(361):40-46.
32. Weir BS. 1996, Genetic Data Analysis II. Sunderland, MA:Sinauer Associates, Inc.
33. Wetmur JG, Kaya AH, Plewinska M, Desnick RJ. 1991a. Molecular characterization of the human δ-aminolevulinate dehydratase 2 (ALAD2) allele: implications for molecular screening of individuals for genetic susceptibility to lead poisoning. Am J Hum Genet 49(4):757-763.
34. Wetmur JG, Lehnert G, Desnick RJ. 1991b. The δ-aminolevulinate dehydratase polymorphism: higher blood lead levels in lead workers and environmentally exposed children with the 1-2 and 2-2 isozymes. Environ Res 56:109-119.
35. Wu MT, Kelsey K, Schwartz J, Sparrow D, Weiss S, Hu H. 2003. A δ-aminolevulinic acid deydratase (ALAD) polymorphism may modify the relationship of low-level lead exposure to uricemia and renal function: the normative aging study. Environ Health Perspect 111:335-340.
36. Ziemsen B, Angerer J, Lehnert G, Benkmann HG, Goedde HW, 1986. Polymorphism of delta-aminolevulinic acid dehydratase in lead-exposed workers. Int Arch Occup Environ Health 58:245-247.
37. Zmuda JM, Cauley JA, Ferrell RE. 2000. Molecular epidemiology of vitamin D receptor gene variants. Epidemiol Rev 22(2):203-217.